🇺🇸 FDA
Pipeline program

FB102

FB102-301

Phase 2 mab active

Quick answer

FB102 for Celiac Disease is a Phase 2 program (mab) at Forte Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Forte Biosciences
Indication
Celiac Disease
Phase
Phase 2
Modality
mab
Status
active

Clinical trials